Latest Listicles

Although UV-Vis spectroscopy is a well-established method, it continues to evolve and is extensively used for the analysis of different types of molecules in varied matrices.

Download this listicle to explore the uses of ELISAs in clinical diagnostics and epidemiology, biopharmaceutical and vaccine development, food safety analysis, environmental analysis and forensics.

Some genetic diseases, like sickle cell anemia, are hereditary and present at birth. Others can be caused by spontaneous mutations, either arising from errors in DNA replication or exposure to environmental factors.

Download this listicle to learn more about the applications of cell therapy, the regulatory landscape of cell therapy, and manufacturing and scalability challenges.

Explore the prevailing trends shaping advanced cryopreservation practices, including seven key trends that underpin effective cryopreservation and biosample management as an essential element in supporting research and cell and gene therapy.

This listicle explores four ways that AI and ML are accelerating the biopharmaceutical lifecycle and two big ways that companies are starting to think about their data differently.

How can you successfully scale your cell and gene therapy fill/finish process to minimize manual involvement, reduce the specialized training required, and deliver high-quality, high-value products, efficiently?

The ever-advancing bioprocess pipeline aims to optimize the manufacturing of biologics, using living organisms or their components. Addressing challenges of high costs, time-consuming assays and processing complexities is a key part of this process.

Download this listicle to learn more about immune checkpoint inhibitors and immune system modulators, adoptive cell therapies and oncolytic viral therapy.

According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Almost one in six deaths were attributable to cancer in 2020, and the incidence rate has been rising. Furthermore, recent estimates predict that as many as one in two people could develop a form of cancer in their lifetime.